Inventor · disambiguated record
Kevin Tomaselli
Also filed as: TOMASELLI KEVIN · TOMASELLI KEVIN J · TOMASELLI KEVIN JAMES
22 granted patents·12 pending applications·206 citations·filing 1995–2016
95Inventor score
Files withIDUN PHARMACEUTICALS INC21IKARIA INC4HUTCHINSON FRED CANCER RES3UNIV JEFFERSON3TOMASELLI KEVIN J1
Top patents by PatentIndex Score
34 records- 0189US7923037B2Liquid chalcogenide compositions and methods of manufacturing and using the sameIKARIA INC·Filed 2008·Granted Apr 12, 2011·8 cites·8 claims
- 0289US6200969B1Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 1997·Granted Mar 13, 2001·38 cites·23 claims
- 0381US6693096B2Treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2002·Granted Feb 17, 2004·11 cites·18 claims
- 0478US6270980B1Rapid methods for identifying modifiers of cellular apoptosis activityIDUN PHARMACEUTICALS INC·Filed 1997·Granted Aug 7, 2001·36 cites·15 claims
- 0576US8226986B2Liquid chalcogenide compositions and methods of manufacturing and using the sameTOMASELLI KEVIN J·Filed 2011·Granted Jul 24, 2012·2 cites·5 claims
- 0675US5786173AMCH4 and MCH5, apoptotic protease, nucleic acids encoding and methods of useIDUN PHARMACEUTICALS INC·Filed 1996·Granted Jul 28, 1998·26 cites·31 claims
- 0773US6790989B2Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2001·Granted Sep 14, 2004·8 cites·25 claims
- 0873US6525024B1Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2001·Granted Feb 25, 2003·6 cites·43 claims
- 0972US6610683B2Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2001·Granted Aug 26, 2003·4 cites·9 claims
- 1072US6528506B2Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2002·Granted Mar 4, 2003·4 cites·7 claims
- 1171US6251614B1Rapid methods for identifying modifiers of cellular apoptosis activityIDUN PHARMACEUTICALS INC·Filed 1999·Granted Jun 26, 2001·25 cites·6 claims
- 1270US6531467B2Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2001·Granted Mar 11, 2003·5 cites·77 claims
- 1369US6515173B1Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2000·Granted Feb 4, 2003·5 cites·24 claims
- 1467US2010143503A1Combinations of nitric oxide and sulfide and methods of use and manufacture thereofIKARIA INC·Filed 2007·Application pending·0 cites
- 1564US6730779B2Antibody that specifically binds an Mch4 polypeptideIDUN PHARMACEUTICALS INC·Filed 2001·Granted May 4, 2004·1 cites·3 claims
- 1662US6716960B2Mch3, a novel apoptotic protease, nucleic acids encoding and methods of useIDUN PHARMACEUTICALS INC·Filed 2003·Granted Apr 6, 2004·0 cites·3 claims
- 1760US2016367593A1Liquid chalcogenide compositions and methods of manufacturing and using the sameHUTCHINSON FRED CANCER RES·Filed 2016·Application pending·0 cites
- 1857US6897296B2Antibody that specifically binds an Mch5 polypeptideUNIV JEFFERSON·Filed 2003·Granted May 24, 2005·0 cites·5 claims
- 1957US2015164942A1Liquid chalcogenide compositions and methods of manufacturing and using the sameHUTCHINSON FRED CANCER RES·Filed 2014·Application pending·0 cites
- 2056US5851815AMCH4 and MCH5, apoptotic proteasesIDUN PHARMACEUTICALS INC·Filed 1996·Granted Dec 22, 1998·17 cites·8 claims
- 2155US6969703B2Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2002·Granted Nov 29, 2005·1 cites·42 claims
- 2255US2007265223A1Compositions and methods of enhancing survivability and reducing injury of cells, tissues, organs, and organisms under hypoxic or ischemic conditionsIKARIA INC·Filed 2007·Application pending·0 cites
- 2355US2002102648A1Mch3, a novel apoptotic protease, nucleic acids encoding and methods of useFiled 2001·Application pending·0 cites
- 2455US2008187604A1Liquid chalcogenide compositions and methods of manufacturing and using the sameIKARIA INC·Filed 2007·Application pending·0 cites
- 2553US2004058850A1Treatment of kidney disease or renal failure using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2652US2005065093A1Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2751US6462175B1Mch3, a novel apoptotic protease, nucleic acids encoding and methods of useUNIV JEFFERSON·Filed 1995·Granted Oct 8, 2002·4 cites·5 claims
- 2851US2014093588A1Combinations of nitric oxide and sulfide and methods of use and manufacture thereofHUTCHINSON FRED CANCER RES·Filed 2013·Application pending·0 cites
- 2951US2006084613A1Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3050US2003092072A1Rapid methods for identifying modifiers of cellular apoptosis activityIDUN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 3148US2001044415A1Inhibition of apoptosis using interleukin-1B-converting enzyme (ICE)/CED-3 family inhibitorsFiled 2001·Application pending·0 cites
- 3240US6518032B1Rapid methods for identifying modifiers of cellular apoptosis activityIDUN PHARMACEUTICALS INC·Filed 1999·Granted Feb 11, 2003·5 cites·32 claims
- 3334US6686459B1Mch3, a novel apoptotic protease, nucleic acids encoding and methods of useIDUN PHARMACEUTICALS INC·Filed 1998·Granted Feb 3, 2004·0 cites·7 claims
- 3432US6287795B1Mch4 and Mch5, apoptotic protease, nucleic acids encoding and methods of useUNIV JEFFERSON·Filed 1999·Granted Sep 11, 2001·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →